In Vivo CD19/CD20 CAR T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma

Clinical trial NCT07775508 · RECRUITING

Trial details

NCT number: NCT07775508
Sponsor: Chinese PLA General Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Lymphoma

Start date: 2026-06-01
Primary completion: 2027-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.